Safety and tolerability meta-analysis of aripiprazole in schizophrenia

被引：0
|
作者：
Stock, E [1 ]
Carson, WH [1 ]
Kaplita, SB [1 ]
Archibald, DG [1 ]
Marcus, R [1 ]
McQuade, RD [1 ]
Iwamoto, T [1 ]
机构：
[1] Bristol Myers Squibb Co, Wallingford, CT 06492 USA
来源：
SCHIZOPHRENIA RESEARCH | 2003年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0920-9964(03)80199-8
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：367 / 367
页数：1
相关论文
共 50 条
  • [31] Efficacy and tolerability of aripiprazole in adolescents with schizophrenia
    Nyilas, M.
    Forbes, A.
    Jin, N.
    Ashfaque, S.
    Iwamoto, T.
    Owen, R.
    Carson, W. H.
    Findling, R. L.
    EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A99 - A99
  • [32] Efficacy and tolerability of aripiprazole in adolescents with schizophrenia
    Forbes, A.
    Nyilas, M.
    Loze, J.
    Werner, C.
    Johnson, B.
    Owen, R.
    Todorov, S.
    Carson, W. H.
    EUROPEAN PSYCHIATRY, 2008, 23 : S115 - S115
  • [33] Safety of aripiprazole for tics in children and adolescents A systematic review and meta-analysis
    Yang, Chunsong
    Yi, Qiusha
    Zhang, Lingli
    Cui, Hao
    Mao, Jianping
    MEDICINE, 2019, 98 (22)
  • [34] A systematic review and meta-analysis of the effects of combined aripiprazole on glycolipid metabolism in schizophrenia
    Wei, Tianbao
    Jiang, Limei
    Zhang, Ruilin
    Su, Hang
    Sun, Zhenjie
    Sun, Junwei
    FRONTIERS IN PSYCHIATRY, 2025, 15
  • [35] Upper gastrointestinal safety and tolerability of oral alendronate: A meta-analysis
    Zhou, Manru
    Zheng, Yayuan
    Li, Jin
    Wu, Jingkai
    Xu, Weiming
    Cui, Liao
    Yao, Weimin
    Liu, Yuyu
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2016, 11 (01) : 289 - 296
  • [36] Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders: A Meta-Analysis Reply
    Stip, Emmanuel
    Moteshafi, Hoda
    DRUG SAFETY, 2012, 35 (12) : 1183 - 1184
  • [37] Efficacy, Tolerability, and Safety of Blonanserin in Schizophrenia: An Updated and Extended Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Kishi, Taro
    Matsui, Yuki
    Matsuda, Yuki
    Katsuki, Asuka
    Hori, Hikaru
    Yanagimoto, Hiroko
    Sanada, Kenji
    Morita, Kiichiro
    Yoshimura, Reiji
    Shoji, Yoshihisa
    Hagi, Katsuhiko
    Iwata, Nakao
    PHARMACOPSYCHIATRY, 2019, 52 (02) : 52 - 62
  • [38] Safety of rTMS for Schizophrenia: A Systematic Review and Meta-analysis
    Blyth, Sophia H.
    Cruz Bosch, Claudia
    Raffoul, Julian J.
    Chesley, Jordyn
    Johnson, Benjamin
    Borodge, Darara
    Sagarwala, Raza
    Masters, Ross
    Brady Jr, Roscoe O.
    Vandekar, Simon
    Ward, Heather Burrell
    SCHIZOPHRENIA BULLETIN, 2024, 51 (02) : 392 - 400
  • [39] Meta-analysis of weight effects with aripiprazole
    Jody, D
    Saha, A
    Iwamoto, T
    Biswas, D
    Lin, CY
    Marcus, R
    McQuade, R
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S290 - S290
  • [40] Meta-analysis of weight effects with aripiprazole
    Jody, D
    Carson, WH
    Iwamoto, T
    Biswas, D
    Lin, C
    Marcus, R
    McQuade, RD
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 358 - 358
12345